Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 60,049 | 5,336 | 2,887 | 9,851 | 6,537 |
| Gross Profit | 60,049 | 5,336 | 2,887 | 9,851 | 6,537 |
| Operating Expenses | 84,012 | 55,499 | 46,981 | 60,812 | 69,983 |
| Operating Income | -23,963 | -50,163 | -44,094 | -50,961 | -63,446 |
| Interest Expense | 0 | 0 | -3,811 | 1,584 | 0 |
| Other Income | 5,089 | 5,144 | -7 | 3,509 | 2,708 |
| Pre-tax Income | -18,874 | -45,019 | -40,290 | -49,036 | -60,738 |
| Net Income Continuous | -18,874 | -45,019 | -40,290 | -49,036 | -60,738 |
| Net Income | $-18,874 | $-45,019 | $-40,290 | $-49,036 | $-60,738 |
| EPS Basic Total Ops | -0.20 | -0.55 | -0.56 | -0.71 | -0.88 |
| EPS Basic Continuous Ops | -0.19 | -0.55 | -0.56 | -0.71 | -0.88 |
| EPS Diluted Total Ops | -0.20 | -0.55 | -0.56 | -0.71 | -0.88 |
| EPS Diluted Continuous Ops | -0.19 | -0.55 | -0.56 | -0.71 | -0.88 |
| EBITDA(a) | $-24,600 | $-49,896 | $-43,334 | $-50,110 | $-62,367 |